Yonemoto Kousuke, Ichimiya Yuko, Sanefuji Masafumi, Kaku Noriyuki, Sakata Ayumi, Baba Rieko, Yamashita Fumiya, Akamine Satoshi, Torio Michiko, Ishizaki Yoshito, Maehara Yoshihiko, Sakai Yasunari, Ohga Shouichi
1 Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
2 Emergency and Critical Care Center, Kyushu University, Fukuoka, Japan.
Clin EEG Neurosci. 2019 Jan;50(1):51-55. doi: 10.1177/1550059418786381. Epub 2018 Jul 9.
Acute encephalopathy with biphasic seizures and reduced diffusion (AESD) is a leading cause of childhood-onset encephalopathy in Japan. Children with AESD frequently develop intractable epilepsy, whereas their treatment options remain to be determined.
We present 2 unrelated girls, who developed AESD at 25 months (case 1) and 12 months of age (case 2). Both cases underwent intensive cares from the first day of illness, whereas severe neurological impairments were left on discharge. They showed repeated signs of epileptic spasms at 2 months (case 1) and 8 months (case 2) after the onset of AESD. Video-monitoring electroencephalograms (EEG) detected the recurrent attacks accompanying slow-wave bursts and transient suppressions of the precedent epileptiform discharges, as typically observed in epileptic spasms.
Intramuscular injection of adrenocorticotropic hormone (ACTH, 0.0125 mg/kg/d) was introduced within 1 month from the onset of epileptic spasms and continued for 2 weeks. The ACTH treatment disrupted the paroxysmal activity in EEG, and it has relieved these patients from epileptic seizures for more than 1 year.
This report illustrates the potential efficacy of ACTH for a group of children with epileptic spasms after AESD.
伴有双相性癫痫发作和弥散受限的急性脑病(AESD)是日本儿童期脑病的主要病因。AESD患儿常发展为难治性癫痫,但其治疗方案仍有待确定。
我们报告2例无血缘关系的女孩,分别在25个月(病例1)和12个月大(病例2)时患AESD。两例患儿自发病首日起均接受了重症监护,但出院时仍遗留严重神经功能障碍。她们在AESD发病后2个月(病例1)和8个月(病例2)出现反复的癫痫痉挛迹象。视频监测脑电图(EEG)检测到伴有慢波爆发和先前癫痫样放电短暂抑制的反复发作,这是癫痫痉挛的典型表现。
在癫痫痉挛发作后1个月内开始肌内注射促肾上腺皮质激素(ACTH,0.0125mg/kg/d),并持续2周。ACTH治疗扰乱了EEG中的阵发性活动,并使这些患者癫痫发作缓解超过1年。
本报告说明了ACTH对一组AESD后癫痫痉挛患儿的潜在疗效。